Chelsea Therapeutics International Revenue Quarterly:
0.00 for March 31, 2013Chelsea Therapeutics International Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.00 |
| Dec. 31, 2012 | 0.00 |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.00 |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
CHTP Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Achillion Pharmaceuticals | 0.00 |
| Merrimack Pharmaceuticals | 14.19M |
| Vanda Pharmaceuticals | 7.92M |
CHTP Revenue Quarterly Rankings
| Overall |
36th percentile 5042 of 8002 |
| Sector |
18th percentile 533 of 650 in Healthcare |
| Industry |
31st percentile 163 of 237 in Biotechnology |
CHTP Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Mar 2009 |
| Maximum | 0.00 | Mar 2009 |
| Average | 0.00 |
